{
    "nct_id": "NCT04054986",
    "official_title": "Phase 1 Study Using First-in-Human Acidosis Imaging With [18F]AlF-cysVar3 pHLIPÂ® (18F-Var3) in Patients With Breast Cancer for Determination of Safety, Biodistribution and Radiation Dosimetry",
    "inclusion_criteria": "* Age 18 years or greater\n* Biopsy-proven breast malignancy\n* >/= 1 viable lesion, >/= 1 cm, confirmed on CT, MR, or FDG PET/CT within 4 weeks of protocol enrollment\n* Newly diagnosed or recurrent disease, on or off therapy\n* ECOG performance of 0-2 *Note: Lesions are considered viable if they are stable or increasing soft tissue lesions, or if they are FDG-avid bone lesions\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Life expectancy < 3 months\n* Pregnancy or lactation\n* Biopsy or other surgical procedures within 48 hours prior to receiving study intervention\n* Patients who cannot undergo PT/CT scanning because of weight limits. PET/CT scanners may not be able to function with patients over 400 pounds",
    "miscellaneous_criteria": ""
}